All AbMole products are for research use only, cannot be used for human consumption.
Zonisamide sodium salt is an antiepileptic compound. It is effective in various animal models of epilepsy and in humans with partial and systemic seizures. Zonisamide sodium also removes nitric oxide (NO).
| Molecular Weight | 234.21 |
| Formula | C8H7N2NaO3S |
| CAS Number | 68291-98-5 |
| Solubility (25°C) | Water: ≥5 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] Deborah Raymond, et al. SGCE Myoclonus-Dystonia
[3] Jing Li, et al. Determination of zonisamide by a coated monolithic column
[4] Piotr Czapiński, et al. Mechanisms of action of antiepileptic drugs
| Related Carbonic Anhydrase Products |
|---|
| hCAIX-IN-5
hCAIX-IN-5 is a potent and selective hCAIX inhibitor with KIs of >10000, >10000, 130.7, 829.1 nM for hCAI, hCAII, hCAIV, hCAIX, respectively. |
| Disulfamide
Disulfamide, an orally active diuretic, is a carbonic anhydrase inhibitor with the IC50 value of 0.07 μM. |
| Quinethazone
Quinethazone is an orally active diuretic agent and is also a weak inhibitor of carbonic anhydrase. |
| Acetazolamide sodium
Acetazolamide sodium is a carbonic anhydrase (CA) IX inhibitor with an IC50 of 30 nM for hCA IX.Acetazolamide reduces the production of intraocular aqueous humor and may be used in glaucoma-related studies. |
| WES-1
WES-1 is an inhibitor of carbonic anhydrase IX (Ki: 55.9 μM). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
